scispace - formally typeset
S

Sita Chopra

Researcher at Stanford University

Publications -  6
Citations -  2512

Sita Chopra is an academic researcher from Stanford University. The author has contributed to research in topics: Medicine & Functional magnetic resonance imaging. The author has an hindex of 2, co-authored 2 publications receiving 2341 citations.

Papers
More filters
Journal ArticleDOI

For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion.

TL;DR: Results suggest that both common and distinct neural systems support various forms of reappraisal and that which particular prefrontal systems modulate the amygdala in different ways depends on the regulatory goal and strategy employed.
Journal ArticleDOI

The neural bases of distraction and reappraisal

TL;DR: In this article, the authors compared distraction and reappraisal and found both similarities and differences between the two forms of emotion regulation and found that both resulted in decreased negative affect, decreased activation in the amygdala, and increased activation in prefrontal and cingulate regions.
Posted ContentDOI

Network Constraints on Longitudinal Grey Matter Changes in First Episode Psychosis

TL;DR: Psychosis- and antipsychotic-related grey matter volume changes are strongly shaped by anatomical brain connectivity, consistent with findings in other neurological disorders and implies that such connections may constrain pathological processes causing brain dysfunction in FEP.
Posted ContentDOI

The effect of using group-averaged or individualized brain parcellations when investigating connectome dysfunction: A case study in psychosis

TL;DR: In this paper , the authors investigated how individual differences in brain organization influenced group comparisons of functional coupling disturbances in a range of clinical disorders using psychosis as a case-study, drawing on fMRI data in 121 early psychosis patients and 57 controls.
Posted ContentDOI

Antipsychotic Effects on Longitudinal Cognitive Functioning in First-Episode Psychosis: A randomised, triple-blind, placebo-controlled study

TL;DR: The findings support the need for careful consideration of the risks and benefits of various antipsychotics and the importance of accounting for their cognitive effects in longitudinal research and show the effects of illness from antipsychotic drugs on cognition over the first 6-months of FEP treatment.